IL75230A - Aminocyclopentyl ethers and their preparation and pharmaceutical formulation - Google Patents

Aminocyclopentyl ethers and their preparation and pharmaceutical formulation

Info

Publication number
IL75230A
IL75230A IL75230A IL7523085A IL75230A IL 75230 A IL75230 A IL 75230A IL 75230 A IL75230 A IL 75230A IL 7523085 A IL7523085 A IL 7523085A IL 75230 A IL75230 A IL 75230A
Authority
IL
Israel
Prior art keywords
aminocyclopentyl
ethers
preparation
pharmaceutical formulation
formulation
Prior art date
Application number
IL75230A
Other languages
English (en)
Other versions
IL75230A0 (en
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848412774A external-priority patent/GB8412774D0/en
Priority claimed from GB848423083A external-priority patent/GB8423083D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL75230A0 publication Critical patent/IL75230A0/xx
Publication of IL75230A publication Critical patent/IL75230A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL75230A 1984-05-18 1985-05-17 Aminocyclopentyl ethers and their preparation and pharmaceutical formulation IL75230A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848412774A GB8412774D0 (en) 1984-05-18 1984-05-18 Carbocyclic compounds
GB848423083A GB8423083D0 (en) 1984-09-12 1984-09-12 Carbocyclic compounds

Publications (2)

Publication Number Publication Date
IL75230A0 IL75230A0 (en) 1985-09-29
IL75230A true IL75230A (en) 1989-07-31

Family

ID=26287761

Family Applications (1)

Application Number Title Priority Date Filing Date
IL75230A IL75230A (en) 1984-05-18 1985-05-17 Aminocyclopentyl ethers and their preparation and pharmaceutical formulation

Country Status (14)

Country Link
US (1) US4880800A (it)
AU (1) AU580777B2 (it)
BE (1) BE902450A (it)
CA (1) CA1243020A (it)
CH (1) CH667646A5 (it)
DE (1) DE3517901A1 (it)
DK (1) DK218985A (it)
FR (1) FR2564464B1 (it)
GB (1) GB2159816B (it)
IL (1) IL75230A (it)
IT (1) IT1180748B (it)
NL (1) NL8501429A (it)
NZ (1) NZ212108A (it)
SE (1) SE8502455L (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5039673A (en) * 1987-06-22 1991-08-13 Glaxo Group Limited Aminocyclopentyl ethers and their preparation and pharmaceutical formulation
KR890000427A (ko) * 1987-06-22 1989-03-14 배리 에이.뉴샘 아미노시클로펜틸 에테르 및 그의 제조방법 및 약제
ATE260240T1 (de) 1998-04-01 2004-03-15 Nortran Pharmaceuticals Inc Aminocyclohexylverbindungen und deren verwendung
AU2528900A (en) * 1999-02-12 2000-08-29 Nortran Pharmaceuticals Inc. Cycloalkyl amine compounds and uses thereof
US6979685B1 (en) 1999-02-12 2005-12-27 Cardiome Pharma Corp. Cycloalkyl amine compounds and uses thereof
US7507545B2 (en) 1999-03-31 2009-03-24 Cardiome Pharma Corp. Ion channel modulating activity method
US7524879B2 (en) 2000-10-06 2009-04-28 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
US7057053B2 (en) 2000-10-06 2006-06-06 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
ATE325789T1 (de) 2003-05-02 2006-06-15 Cardiome Pharma Corp Aminocyclohexylether-verbindungen und deren verwendung
US20090041841A1 (en) * 2003-05-02 2009-02-12 Cardiome Pharma Corp. Controlled release tablet formulations for the prevention of arrhythmias
US7345086B2 (en) 2003-05-02 2008-03-18 Cardiome Pharma Corp. Uses of ion channel modulating compounds
US7674820B2 (en) 2003-08-07 2010-03-09 Cardiome Pharma Corp. Ion channel modulating activity I
US7345087B2 (en) 2003-10-31 2008-03-18 Cardiome Pharma Corp. Aminocyclohexyl ether compounds and uses thereof
US7977373B2 (en) 2004-04-01 2011-07-12 Cardiome Pharma Corp. Prodrugs of ion channel modulating compounds and uses thereof
US8058304B2 (en) 2004-04-01 2011-11-15 Cardiome Pharma Corp. Merged ion channel modulating compounds and uses thereof
US8263638B2 (en) 2004-11-08 2012-09-11 Cardiome Pharma Corp. Dosing regimens for ion channel modulating compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2658401A1 (de) * 1976-12-23 1978-07-06 Merck Patent Gmbh Cyclopentan-1-amine, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
NL7905375A (nl) * 1978-07-11 1980-01-15 Glaxo Group Ltd Prostanoiden, werkwijze voor het bereiden daarvan, en daarop gebaseerde farmaceutische preparaten.
AU542949B2 (en) * 1980-01-09 1985-03-28 Glaxo Group Limited Prostanoid compounds
US4345984A (en) * 1981-03-02 1982-08-24 The Procter & Gamble Company Novel prostaglandin analogues and process for making same
GB8307099D0 (en) * 1983-03-15 1983-04-20 Glaxo Group Ltd Carbocyclic compounds
US4613597A (en) * 1983-09-06 1986-09-23 Glaxo Group Limited Aminocyclopentanes and their preparation and pharmaceutical formulation

Also Published As

Publication number Publication date
GB2159816B (en) 1989-05-24
CA1243020A (en) 1988-10-11
IL75230A0 (en) 1985-09-29
DE3517901A1 (de) 1985-12-12
GB2159816A (en) 1985-12-11
AU580777B2 (en) 1989-02-02
IT8548093A1 (it) 1986-11-17
FR2564464B1 (fr) 1988-09-02
IT1180748B (it) 1987-09-23
SE8502455D0 (sv) 1985-05-17
NZ212108A (en) 1988-10-28
AU4262585A (en) 1985-11-21
CH667646A5 (de) 1988-10-31
NL8501429A (nl) 1985-12-16
SE8502455L (sv) 1985-11-19
DK218985A (da) 1985-11-19
GB8512591D0 (en) 1985-06-19
BE902450A (fr) 1985-11-18
FR2564464A1 (fr) 1985-11-22
IT8548093A0 (it) 1985-05-17
DK218985D0 (da) 1985-05-17
US4880800A (en) 1989-11-14

Similar Documents

Publication Publication Date Title
AU578724B2 (en) Dihydropyridines and their preparation and pharmaceutical formulation
IL79266A (en) Aralkylpiperidinylbenzyl alcohols,their preparation and pharmaceutical compositions containing them
GR860342B (en) 11b- phenyl-gonane their preparation and pharmaceutical preparations containing them
IL80624A0 (en) Substituted benzyl ethers,their preparation and pharmaceutical compositions containing them
GB2159816B (en) Aminocyclopentyl ethers and their preparation and pharmaceutical formulation
GB2174702B (en) Cyclopentyl ethers and their preparation and pharmaceutical formulation
IL79039A0 (en) 4-oxoquinolinesulfonamides,their preparation and pharmaceutical compositions containing them
IL86814A0 (en) Aminocyclopentyl ethers and their preparation and pharmaceutical formulation
GB2179945B (en) New saccharides, their preparation and pharmaceutical compositions containing them
NZ215065A (en) Preparation of 3-substituted 1-alkylamino-2-propanols and arylglycidyl ethers and pharmaceutical compositions
GB2146023B (en) Aminocyclopentanes and their preparation and pharmaceutical formulation
ZA853755B (en) Aminocyclopentyl ethers and their preparation and pharmaceutical formulation
ZA849442B (en) Sphingosine derivatives,their preparation and pharmaceutical formulation
ZA884453B (en) Aminocyclopentyl ethers and their preparation and pharmaceutical formulation
GR861666B (en) New saccharides their preparation and pharmaceutical compositions containing them
EP0268389A3 (en) Cyclopenthyl ethers and their preparation and pharmaceutical formulation
ZA846965B (en) Aminocyclopentanes and their preparation and pharmaceutical formulation
ZW20286A1 (en) Cyclopentyl ethers and their preparations and pharmaceutical formulation
DE3467298D1 (en) Prostaglandin-containing pharmaceutical composition and its preparation
GB2211503B (en) New saccharides, their preparation and pharmaceutical compositions containing them
IL85065A0 (en) Anti-inflammatory acylphenyl ethers,their preparation and pharmaceutical compositions containing them